ImmunityBio Inc (NASDAQ: IBRX) is 4.98% higher on its value in year-to-date trading and has touched a low of $1.25 and a high of $6.93 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The IBRX stock was last observed hovering at around $4.91 in the last trading session, with the day’s gains setting it 0.36%.
Currently trading at $5.27, the stock is -5.07% and 3.08% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 4.56 million and changing 7.33% at the moment leaves the stock 56.15% off its SMA200. IBRX registered 121.43% gain for a year compared to 6-month gain of 273.76%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -12.02% loss in the last 1 month and extending the period to 3 months gives it a 46.39%, and is 3.13% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 9.92% over the week and 11.45% over the month.
ImmunityBio Inc (IBRX) has around 628 employees, a market worth around $3.55B and $0.62M in sales. Profit margin for the company is -93761.41%. Distance from 52-week low is 321.60% and -23.95% from its 52-week high. The company has generated returns on investments over the last 12 months (-201.17%).
The EPS is expected to grow by 40.87% this year.
ImmunityBio Inc (IBRX) Top Institutional Holders
The shares outstanding are 670.87M, and float is at 136.93M with Short Float at 40.00%.
ImmunityBio Inc (IBRX) Insider Activity
The most recent transaction is an insider purchase by BLASZYK MICHAEL D,the company’sDirector. SEC filings show that BLASZYK MICHAEL D bought 71,915 shares of the company’s common stock on Jun 05 ’23 at a price of $2.75 per share for a total of $0.2 million. Following the purchase, the insider now owns 71915.0 shares.
ImmunityBio Inc disclosed in a document filed with the SEC on Jun 02 ’23 that Brennan John Owen (Director) bought a total of 25,000 shares of the company’s common stock. The trade occurred on Jun 02 ’23 and was made at $2.83 per share for $70700.0. Following the transaction, the insider now directly holds 25000.0 shares of the IBRX stock.
Still, SEC filings show that on Jun 01 ’23, Clark Wesley (Director) acquired 7,000 shares at an average price of $2.91 for $20370.0. The insider now directly holds 8,000 shares of ImmunityBio Inc (IBRX).
